CATTALINI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 6.110
EU - Europa 4.154
AS - Asia 3.667
SA - Sud America 848
AF - Africa 88
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 7
Totale 14.894
Nazione #
US - Stati Uniti d'America 6.000
PL - Polonia 1.608
SG - Singapore 1.333
CN - Cina 978
BR - Brasile 706
HK - Hong Kong 497
FR - Francia 470
UA - Ucraina 469
IT - Italia 404
DE - Germania 382
VN - Vietnam 347
FI - Finlandia 233
GB - Regno Unito 171
RU - Federazione Russa 144
TR - Turchia 138
IE - Irlanda 106
IN - India 90
ID - Indonesia 60
BD - Bangladesh 55
CA - Canada 52
AR - Argentina 51
MX - Messico 35
EC - Ecuador 29
IQ - Iraq 27
NL - Olanda 27
SE - Svezia 25
ZA - Sudafrica 25
BE - Belgio 23
ES - Italia 22
JP - Giappone 21
AU - Australia 19
AT - Austria 18
CO - Colombia 18
PK - Pakistan 18
SA - Arabia Saudita 15
MA - Marocco 14
CZ - Repubblica Ceca 10
EG - Egitto 10
VE - Venezuela 10
PE - Perù 9
UZ - Uzbekistan 9
DZ - Algeria 8
KG - Kirghizistan 8
NG - Nigeria 8
PH - Filippine 8
PY - Paraguay 8
AZ - Azerbaigian 7
KE - Kenya 7
UY - Uruguay 7
CH - Svizzera 6
IL - Israele 6
TN - Tunisia 6
CL - Cile 5
DK - Danimarca 5
EU - Europa 5
HN - Honduras 5
JO - Giordania 5
LT - Lituania 5
SN - Senegal 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
HU - Ungheria 4
IR - Iran 4
MY - Malesia 4
NP - Nepal 4
AL - Albania 3
AM - Armenia 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
LB - Libano 3
NI - Nicaragua 3
PS - Palestinian Territory 3
QA - Qatar 3
RO - Romania 3
CR - Costa Rica 2
EE - Estonia 2
GR - Grecia 2
JM - Giamaica 2
KH - Cambogia 2
KZ - Kazakistan 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DM - Dominica 1
FK - Isole Falkland (Malvinas) 1
GI - Gibilterra 1
GT - Guatemala 1
IM - Isola di Man 1
KN - Saint Kitts e Nevis 1
KR - Corea 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 14.882
Città #
Warsaw 1.607
Singapore 657
Fairfield 628
Ashburn 558
Woodbridge 515
Hong Kong 495
Jacksonville 356
Houston 349
The Dalles 275
San Jose 258
Beijing 246
Seattle 244
Cambridge 225
Wilmington 218
Ann Arbor 206
Chandler 186
New York 174
Princeton 165
Helsinki 161
Los Angeles 128
Istanbul 115
Lauterbourg 113
Ho Chi Minh City 109
Dublin 106
Nanjing 88
Munich 81
Dong Ket 70
Brescia 66
Des Moines 64
São Paulo 64
Redondo Beach 54
Hanoi 53
Chicago 49
Council Bluffs 49
Moscow 49
Milan 48
San Francisco 44
Shenyang 42
Santa Clara 41
Dallas 40
Jakarta 39
Shanghai 39
Buffalo 38
Nanchang 38
San Diego 36
Orem 30
Changsha 26
Dearborn 25
Chennai 23
Lancaster 23
Turku 23
Hebei 22
London 22
Rome 22
Nuremberg 21
Phoenix 21
Rio de Janeiro 21
Tianjin 21
Brussels 20
Denver 20
Boardman 19
Frankfurt am Main 19
Jinan 19
Lappeenranta 18
Atlanta 17
Tokyo 17
Toronto 16
Montreal 15
Romola 15
Assemini 14
Belo Horizonte 14
Johannesburg 14
Ningbo 14
Paris 14
Poplar 14
Guangzhou 13
Zhengzhou 13
Baghdad 12
Mexico City 12
Salt Lake City 12
Goiânia 11
Porto Alegre 11
Stockholm 11
Brasília 10
Brooklyn 10
Campinas 10
Dhaka 10
Haiphong 10
Quito 10
Amsterdam 9
Boston 9
Da Nang 9
Düsseldorf 9
Hyderabad 9
Salvador 9
Abuja 8
Bishkek 8
Bogotá 8
Cascina 8
Guarulhos 8
Totale 10.014
Nome #
Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): An open-label, phase II study 328
Basic Characteristics of Adults with Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenopathy Syndrome in Comparison with the Typical Pediatric Expression of Disease 327
The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry 316
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 303
Developing a Predictive Score for Chronic Arthritis among a Cohort of Children with Musculoskeletal Complaints - The Chronic Arthritis Score Study 290
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept 267
A national cohort study on pediatric Behçet's disease: Cross-sectional data from an Italian registry 259
Efficacy of adalimumab in young children with juvenile idiopathic arthritis and chronic uveitis: A case series 252
Interleukin-1: Ariadne's Thread in Autoinflammatory and Autoimmune Disorders 250
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis 244
When flexibility is not necessarily a virtue: a review of hypermobility syndromes and chronic or recurrent musculoskeletal pain in children 234
Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder? 233
Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis 230
Canakinumab for the treatment of autoinflammatory recurrent fever syndromes 211
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 197
Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation. 195
Clinical and Laboratory Features of 184 Italian Pediatric Patients Affected with Selective IgA Deficiency (SIgAD): a Longitudinal Single-Center Study 185
IPSC-DERIVED NEURONS AS AN IN VITRO MODEL FOR THE STUDY OF INTERFERONOPATHIES WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT 181
Allele *1 of HS1.2 enhancer associates with selective IgA deficiency and IgM concentration. 176
Autosomal recessive agammaglobulinemia: novel insights from mutations in Ig-beta 175
Body experiences, emotional competence, and psychosocial functioning in juvenile idiopathic arthritis. 173
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 168
The change in Ig regulation from children to adults disconnects the correlation with the 3'RR hs1.2 polymorphism 163
DISCRIMINATION AMONG MONOGENIC AND ACQUIRED DISEASE WITH INFLAMMATORY AND AUTOIMMUNE COMPONENT THROUGH THE IN VITRO STUDY OF SIGNAL TRANSDUCERS OF TYPE I INTERFERON 159
In silico validation of the autoinflammatory disease damage index 156
Profound T-cell defects in Dubowitz syndrome 153
Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children 153
Aicardi Goutieres Syndrome: New Insights on a Novel Set of Inborn Errors of Immunity 151
The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry 147
Development of the autoinflammatory disease damage index (ADDI) 146
Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome 145
Establishment of three iPSC lines from fibroblasts of a patient with Aicardi Goutières syndrome mutated in RNaseH2B 142
Exploring Autoimmunity in a Cohort of Children with Genetically Confirmed Aicardi–Goutières Syndrome 141
Anakinra drug retention rate and predictive factors of long-term response in systemic juvenile idiopathic arthritis and adult onset still disease 139
Condylar asymmetry in patients with juvenile idiopathic arthritis: Could it be a sign of a possible temporomandibular joints involvement? 135
Chronic nonbacterial osteomyelitis may be associated with renal disease and bisphosphonates are a good option for the majority of patients 134
Generation of three isogenic induced Pluripotent Stem Cell lines (iPSCs) from fibroblasts of a patient with Aicardi Goutières Syndrome carrying a c.2471G>A dominant mutation in IFIH1 gene 134
Cryopyrin-associated periodic syndromes in Italian Patients: Evaluation of the rate of somatic NLRP3 mosaicism and phenotypic characterization 132
The multifaceted presentation of chronic recurrent multifocal osteomyelitis: A series of 486 cases from the Eurofever international registry 132
Differential impact of high and low penetrance TNFRSF1A gene mutations on conventional and regulatory CD4+ T cell functions in TNFR1-associated periodic syndrome 131
Cooperative intervention to assist children with HIV-infection in Burkina Faso: The Brescia experience during the pilot phase of the ESTHER Project. 130
Follow-up and quality of life of patients with cryopyrin-associated periodic syndromes treated with Anakinra 128
Sex Differences in Pediatric Rheumatology 128
Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis 127
Mutations of the X-linked lymphoproliferative disease gene SH2D1A mimicking common variable immunodeficiency. 124
Recurrent migratory angioedema as cutaneous manifestation in a familiar case of TRAPS: dramatic response to Anakinra 121
Musculoskeletal pain in children, when hypermobility is the problem 121
Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: Analysis by the Pharmachild Safety Adjudication Committee 121
Differentiating PFAPA syndrome from monogenic periodic fevers. 120
Systemic and organ involvement in monogenic autoinflammatory disorders: a global review filtered through internists’ lens 119
Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils. 118
Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A gene. 116
Generation of three iPSC lines from fibroblasts of a patient with Aicardi Goutières Syndrome mutated in TREX1 116
Overview of fever of unknown origin in adult and paediatric patients 105
Dysregulation of the immune system in Aicardi-Goutières syndrome: another example in a TREX1-mutated patient 101
Recent advances in the use of Anti-TNFα therapy for the treatment of juvenile idiopathic arthritis 99
Contraception in adolescents with systemic lupus erythematosus 98
Clinical impact of MEFV mutations in children with periodic fever in a prevalent western European Caucasian population. 97
Serum amyloid protein A concentration in cryopyrin-associated periodic syndromes patients treated with interleukin-1 beta antagonist 97
INSAID Variant Classification and Eurofever Criteria Guide Optimal Treatment Strategy in Patients with TRAPS: Data from the Eurofever Registry 96
Development and implementation of the AIDA International Registry for patients with Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis syndrome 93
Longitudinal Characterization of Immune Response in a Cohort of Children Hospitalized with Multisystem Inflammatory Syndrome 91
Pitfalls of flow cytometric analysis by dihidrorodamyne-123 in the diagnosis of chronic granulomatous disease. 91
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Scleritis 90
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-alpha therapy in childhood chronic uveitis 90
Prevention of Flare Recurrences in Childhood-Refractory Chronic Uveitis: An Open-LabelComparative Study of Adalimumab Versus Infliximab 89
Case Report: The JAK-Inhibitor Ruxolitinib Use in Aicardi-Goutieres Syndrome Due to ADAR1 Mutation 89
PFAPA syndrome and Behçet’s disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists 88
Demographic, clinical and therapeutic findings in a monocentric cohort of adult patients with suspected PFAPA syndrome 88
Intervento di Cooperazione sanitaria per l'assistenza ai bambini affetti da HIV/AIDS in Burkina Faso: l'esperienza della Clinica Pediatrica di Brescia. 87
Favourable and sustained response to anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) with or without AA amyloidosis. 87
Development and Implementation of the AIDA International Registry for Patients With Undifferentiated Systemic AutoInflammatory Diseases 86
Musculoskeletal manifestations in hereditary periodic fever syndromes 84
Paediatric MAS/HLH caused by a novel monoallelic activating mutation in p110δ 84
Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): a diagnostic and treatment guidance from the Rheumatology Study Group of the Italian Society of Pediatrics 83
Pitfalls of flow cytometric analysis by dihydrorodamine-123 in the diagnosis of chronic granulomatous disease 82
Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA Network 82
Predicting duration of beneficial effect of joint injection among children with chronic arthritis by measuring biomarkers concentration in synovial fluid at the time of injection. 81
Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF- α Receptor - Associated Periodic Syndrome (TRAPS): A Series of 80 Cases from the AIDA Network 81
Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-γ Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome 81
A patient-driven registry on Behçet's disease: the AIDA for patients pilot project 80
The Spectrum of Manifestations of Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV2) Infection in Children: What We Can Learn From Multisystem Inflammatory Syndrome in Children (MIS-C) 79
Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome-Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA Network 79
Treatment response to Janus kinase inhibitor in a child affected by Aicardi-Goutières syndrome 77
OBSIDIAN - real-world evidence of originator to biosimilar drug switch in juvenile idiopathic arthritis 76
Early anakinra treatment improves cardiac outcome of multisystem inflammatory syndrome in children, regardless of disease severity 75
Inflammatory pathways signal transducers analysis in iPSC-derived neurons and 3D cerebral organoids 75
Prevalence of cranial involvement in a cohort of Italian patients with chronic non-bacterial osteomyelitis 74
Covid-19 and autoimmunity 74
The HyperPed-COVID international registry: Impact of age of onset, disease presentation and geographical distribution on the final outcome of MIS-C 74
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial 74
iPSC-derived 3d brain organoids cultured in a bioreactor as an in vitro model for the study of microcephaly in Aicardi Goutières syndrome 73
iPSC-derived 3d brain organoids cultured in a bioreactor as an in vitro model for the study of microcephaly in Aicardi Goutières syndrome. 72
Cardiac MRI in midterm follow-up of MISC: a multicenter study 72
Monitoring of Adverse Events and Safety in Autoinflammatory Diseases: Real-Life Data from the Eurofever Registry 71
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease 71
Updated overview of molecular pathways involved in the most common monogenic autoinflammatory diseases 70
Reumatologia per il pediatra. Cap 43 La PFAPA 70
Pathogenesis of Autoimmune Cytopenias in Inborn Errors of Immunity Revealing Novel Therapeutic Targets 70
Preliminary data revealing efficacy of Streptococcus salivarius K12 (SSK12) in Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis (PFAPA) syndrome: A multicenter study from the AIDA Network PFAPA syndrome registry 69
Totale 13.271
Categoria #
all - tutte 70.008
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.008


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021249 0 0 0 0 0 0 0 0 0 0 135 114
2021/2022727 64 104 28 55 6 39 29 59 35 86 56 166
2022/2023609 91 6 8 59 50 175 11 53 91 7 29 29
2023/2024867 53 20 92 65 25 150 30 37 250 8 17 120
2024/20252.325 11 28 31 358 241 161 214 106 298 186 385 306
2025/20264.502 416 589 377 730 402 306 634 163 296 426 163 0
Totale 15.148